4//SEC Filing
Strauss David P 4
Accession 0001707925-25-000071
CIK 0001707925other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 3:33 PM ET
Size
23.1 KB
Accession
0001707925-25-000071
Insider Transaction Report
Form 4
LINDE PLCLIN
Strauss David P
Executive VP, Chief HR Officer
Transactions
- Sale
Ordinary Shares
2025-05-16$457.04/sh−1,987.16$908,212→ 22,639.04 total(indirect: By Trust)
Holdings
- 1,949.383(indirect: By 401(k))
Ordinary Shares
- 1,235
Restricted Stock Units
→ Ordinary Shares (1,235 underlying) - 8,010
Stock Options (right to buy)
Exercise: $465.29Exp: 2034-03-07→ Ordinary Shares (8,010 underlying) - 8,515
Stock Options (right to buy)
Exercise: $354.14Exp: 2033-03-07→ Ordinary Shares (8,515 underlying) - 20,985
Stock Options (right to buy)
Exercise: $176.63Exp: 2029-03-20→ Ordinary Shares (20,985 underlying) - 1,290
Restricted Stock Units
→ Ordinary Shares (1,290 underlying) - 10,200
Stock Options (right to buy)
Exercise: $270.99Exp: 2032-03-07→ Ordinary Shares (10,200 underlying) - 276.362
Deferred Stock Units
→ Ordinary Shares (276.362 underlying) - 15,925
Stock Options (right to buy)
Exercise: $253.68Exp: 2031-03-08→ Ordinary Shares (15,925 underlying) - 4,688.993
Ordinary Shares
- 1,278
Restricted Stock Units
Exercise: $0.00→ Ordinary Shares (1,278 underlying) - 8,973
Stock Options (right to buy)
Exercise: $468.77Exp: 2035-03-07→ Ordinary Shares (8,973 underlying) - 7,545
Stock Options (right to buy)
Exercise: $154.00Exp: 2028-02-27→ Ordinary Shares (7,545 underlying) - 20,870
Stock Options (right to buy)
Exercise: $173.13Exp: 2030-03-09→ Ordinary Shares (20,870 underlying)
Footnotes (14)
- [F1]The price reported is the weighted average sale price per share. The sale prices ranged from $456.94 to $457.14 per share. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F10]This option vested in full over three years beginning on March 9, 2021.
- [F11]This option vested in full over three years beginning March 20, 2020.
- [F12]This option vested in full over three years beginning on February 27, 2019.
- [F13]Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
- [F14]Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
- [F2]Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
- [F3]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
- [F4]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
- [F5]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
- [F6]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
- [F7]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
- [F8]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
- [F9]This option vested in full over three years beginning on March 8, 2022.
Documents
Issuer
LINDE PLC
CIK 0001707925
Entity typeother
Related Parties
1- filerCIK 0001705851
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 3:33 PM ET
- Size
- 23.1 KB